Brigham and Women’s Hospital
Department of Medicine
Division of Pharmacoepidemiology & Pharmacoeconomics
1620 Tremont Street, Suite 3030,
Boston, MA 02120
Phone: 617-278-0932 | Fax: 617-278-0930
Rishi J Desai, MS, PhD, is an Instructor of Medicine at Harvard Medical School and an Associate Epidemiologist in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital. His research focuses on generating high-quality evidence for comparative safety and effectiveness of drug treatments for chronic diseases, especially in patient populations typically underrepresented in clinical trials, including pregnant women, the elderly, and patients with multiple chronic conditions. His research projects have mainly concentrated on rheumatology and cardiology; where he has extensively used observational study designs as well as systematic reviews to answer clinically important research questions related to drug effects on a variety of health outcomes. He also has a special interest in applied methodological research aimed at improving confounding control in observational studies.
Dr. Desai received his research doctorate in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill and his Master’s in Pharmacy Administration from the University of Houston. He is clinically trained with a Bachelor’s degree in Pharmacy from the Sardar Patel University, Gujarat, India.
Selected Publications | Current PubMed Search Results
- Desai RJ, Huybrechts KF, Hernandez-Diaz S, Mogun H, Patorno E, Kaltenbach K, Kerzner LS, Bateman BT. Exposure to prescription opioid analgesics in utero and risk of neonatal abstinence syndrome: population based cohort study. BMJ. 2015; 350:h2102
- Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, Levin R, Mogun H, Hernandez-Diaz S. Antidepressant Use Late in Pregnancy and Risk of Persistent Pulmonary Hypertension of the Newborn. JAMA. 2015 June 2;313(21):2142-2151.
- Desai RJ, Eddings W, Liao KP, Solomon DH, Kim SC. Disease modifying anti-rheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis. Arthritis Care & Research. 2015;67:457-466.
- Desai RJ, Solomon DH, Weinblatt M, Shadick N, Kim SC. An external validation study reporting poor correlation between the claims based index for rheumatoid arthritis severity and the disease activity score. Arthritis Research & Therapy. 2015;17(1):83.
- Bateman B, Hernandez-Diaz S, Fischer M, Seely E, Ecker J, Franklin J, Desai RJ, Mogun H, Avorn J, Huybrechts K. Statins and congenital malformations: A cohort study. BMJ. 2015;350:h1035.
- Desai RJ, Rao JK, Hansen RA, Fang G, Maciejewski M, Farley JF. TNF-α inhibitor treatment and the risk of incident cardiovascular events in patients with early rheumatoid arthritis. Journal of Rheumatology. 2014;41 (11):2129-2136.
- Desai RJ, Hernandez-Diaz S, Bateman B, Huybrechts K. Increase in prescription opioid use during pregnancy among Medicaid-enrolled women. Obstetrics & Gynecology. 2014;123(5):997-1002.
- Desai RJ, Williams CE, Greene SB, Pierson S, Caprio A, Hansen RA. Exploratory evaluation of medication classes most commonly involved in nursing home medication errors. Journal of American Medical Directors’ Association. 2013;14 (6):403-408.
- Desai RJ, Hansen RA, Rao J, Harden E, Yuen A, Jonas D, Roubey R, Jonas B, Gartlehner G, Lux L, Donahue K. Mixed treatment comparison of the treatment discontinuations of biologic disease modifying antirheumatic agents for rheumatoid arthritis. Annals of Pharmacotherapy. 2012;46(11):1491-1505.
- Desai RJ, Ashton C, Deswal A, Morgan R, Mehta H, Chen H, Aparasu R, Johnson M. Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in the patients with chronic heart failure. Pharmacoepidemiology and Drug Safety. 2012;21(3):233-240.